Safety of ginger use in pregnancy: results from a large population-based cohort study
- 1.5k Downloads
The objective of the study was to examine the safety of ginger use during pregnancy on congenital malformations and selected pregnancy outcomes.
The Norwegian Mother and Child Cohort study, a large population-based cohort, provided the data used in this study. Our study population consisted of 68,522 women. Data on ginger use and socio-demographic factors were retrieved from three self-administered questionnaires completed by the women during weeks 17 and 30 of the pregnancy and when their child was 6 months old. Data on pregnancy outcomes were provided by the Medical Birth Registry of Norway.
Among the 68,522 women in the study, 1,020 (1.5 %) women reported using ginger during pregnancy. The use of ginger during pregnancy was not associated with any increased risk of congenital malformations. No increased risk for stillbirth/perinatal death, preterm birth, low birth weight, or low Apgar score was detected for the women exposed to ginger during pregnancy compared to women who had not been exposed.
Use of ginger during pregnancy does not seem to increase the risk of congenital malformations, stillbirth/perinatal death, preterm birth, low birth weight, or low Apgar score. This finding is clinically important for health care professionals giving advice to pregnant women with NPV.
KeywordsPregnancy Ginger Nausea Herbal medicine Congenital malformations Pregnancy outcome
The Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health and the Ministry of Education and Research, NIH/NIEHS (contract no NO-ES-75558), NIH/NINDS (grant no.1 UO1 NS 047537-01), and the Norwegian Research Council/FUGE (grant no. 151918/S10). We are grateful to all of the participants and their families for taking part in this study. We thank Gro C Havnen and Ingebjørg Sandøy Rødahl for their help identifying and classifying the herbal products.
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Blumenthal M, Goldberg A, Brinkmann J (Eds.) (2000) Herbal Medicine. Expanded Comission E Monographs. Integrative Medicine, NewtonGoogle Scholar
- 2.Natural medicines comprehensive database (2012) Ginger monograph. Natural medicines comprehensive database. http://naturaldatabase.therapeuticresearch.com/home.aspx?cs=&s=ND. Accessed 16 March 2012
- 18.Ensiyeh J, Sakineh MA (2008) Comparing ginger and vitamin B6 for the treatment of nausea and vomiting in pregnancy: a randomised controlled trial. Midwifery. doi: 10.1016/j.midw.2007.10.013Google Scholar
- 22.Goldstein L, Berkovitch M (2007) Antiemetics. In: Schaefer C, Peters P, Miller R (eds) Drugs during pregnancy and lactation, 2nd edn. Academic Press, London, pp 82–83Google Scholar
- 23.Mills E, Dugoua JJ, Perri D, Koren G (2006) Herbal Medicines in Pregnancy and Lactation. An evidence-Based Approached. Taylor & Francis Group, London and New YorkGoogle Scholar
- 24.Briggs GG, Freeman RK, Yaffe SJ (2008) Drugs in Pregnancy and Lactation,8th edn. Lippinncott Williams & Wilkins, PhiladelphiaGoogle Scholar
- 28.Bordia A, Verma SK, Srivastava KC (1997) Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenumgraecum L.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids 56:379–384PubMedCrossRefGoogle Scholar
- 33.Norwegian Institute of Public Health (2010) The Norwegian Mother and Child Cohort Study. Norwegian Institute of Public Health. http://www.fhi.no/eway/default.aspx?pid=238&trg=MainArea_5811&MainArea_5811=5903:0:15,4329:1:0:0:::0:0. Accessed 02 February 2012
- 35.Norwegian Institute of Public Health The Nowegian Mother and Child Cohort Study. Questionnaire 1. Norwegian Institute of Public Health. http://www.fhi.no/dokumenter/1f32a49514.pdf. Accessed 01 March 2012
- 36.Norwegian Institute of Public Health The Nowegian Mother and Child Cohort Study. Questionnaire 3. Norwegian Institute of Public Health. http://www.fhi.no/dokumenter/7b6b32b0cd.pdf. Accessed 01 March 2012
- 37.Norwegian Institute of Public Health The Nowegian Mother and Child Cohort Study. Questionnaire 4. Norwegian Institute of Public Health. http://www.fhi.no/dokumenter/9ecca1c459.pdf. Accessed 01 March 2012
- 39.Norwegian Institute of Public Health (2012) Medical Birth Registry of Norway. Norwegian Institute of Public Health. http://www.fhi.no/eway/default.aspx?pid=238&trg=MainArea_5811&MainArea_5811=5895:0:15,3320:1:0:0:::0:0&MainLeft_5895=5825:73560::1:5896:4:::0:0. Accessed 27 February 2012
- 40.World Health Organization (2010) International statistical classification of disease and related health problems, 10th revision. World Health Organization. http://apps.who.int/classifications/icd10/browse/2010/en. Accessed 27 February 2012
- 41.Norwegian Institute of Public Health (2011) Definisjonsrapporter for variabler i Medisinsk fødselsregister (in Norwegian) In English: Definition report for variables in the Medical Birth Registry of Norway. Norwegian Institute of Public Health. http://www.fhi.no/dokumenter/8105c63e8e.pdf. Accessed 01 March 2012
- 42.Rothman KJ, Greenland S, Lash TL (2008) Modern Epidemiology, 3rd edn. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar
- 43.DSS Research (2012) Researcher's Tool Kit. Statistical Power Calculator. Two Sample Tests Using Percentage Values. DSS Research. http://www.dssresearch.com/toolkit/spcalc/power_p2.asp. Accessed 29 February 2012
- 51.Nilsen RM, Vollset SE, Gjessing HK, Skjaerven R, Melve KK, Schreuder P, Alsaker ER, Haug K, Daltveit AK, Magnus P (2009) Self-selection and bias in a large prospective pregnancy cohort in Norway. Paediatr Perinat Epidemiol 23:597–608. doi: 10.1111/j.1365-3016.2009.01062.x PubMedCrossRefGoogle Scholar